(4-(1,2,4,5-Tetrazin-3-yl)phenyl)methanamine hydrochloride, 97%, 250mg

2'-(Chloromethyl)-4-fluoro-5-isopropyl-2-methoxy-4'-(trifluoromethyl)-1,1'-biphenyl, 95.0%, 250mg

(R)-4-(1-((tert-Butoxycarbonyl)amino)ethyl)benzoic acid, 95.0%, 250mg

3-(5-Methyl-7-oxo-4,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)-propionic acid, 95.0%, 2.5g

4-bromo-5-methoxy-2-methylpyridine, 95.0%, 5g

(+/-)-a-Methoxy-a-trifluoromethylphenylacetyl chloride, 98.0%, 5g

2-Amino-4-(1-naphthyl)thiazole>97.0%(GC)(T)5g

2,5-Diphenyloxazole [for scintillation spectrometry]>99.0%(HPLC)(N)100g

4,4'-(Propane-1,3-diylbis(oxy))bis(5-methoxy-2-nitrobenzoic acid), 95%, 1g

6-Phenoxynicotinonitrile, 95.0%, 250mg

ROTI® SampleLyse Tissus mous 1, 250 pièces 250 pièces

2-(Ethylsulfonyl)aniline, 95.0%, 5g

Na-Boc-Ne-Azido-L-Lysine cyclohexylammonium salt, 99.0%, 25g